When medtech pioneer Alfred Mann died in February 2016, he left behind a rich legacy of pure innovation and patient impact spanning the breadth of healthcare, from cardiology to hearing impairment, blindness and diabetes that will improve the lives of patients for decades to come. Extending and advancing that legacy is now the mission of Dr. […]
Business/Financial News
Wall Street Beat | Earnings Reports | Funding Roundup | Mergers & Acquisitions | Initial Public Offerings | Legal News
ResMed puts $225m on the table for Propeller Health
ResMed (NYSE:RMD) said today that it inked a deal to acquire Propeller Health and its digital medicine platform for $225 million in cash. Propeller Health, which sells small sensors that attach to inhalers and track medication use, will operate as a standalone business under ResMed’s respiratory care portfolio. Get the full story at our sister site, Drug Delivery […]
Judge threatens to delay or even spike $70m CVS-Aetna merger
A federal judge last week reportedly threatened to derail the already-closed $70 billion buyout of health insurer Aetna (NYSE:AET) by CVS Health (NYSE:CVS), saying he felt “kept in the dark, kind of like a mushroom.” At a normally routine hearing last week prior to approving the deal, Judge Richard Leon, of the U.S. District Court for the District of Columbia, […]
Ocular Therapeutix wins FDA nod for drug-delivery eye insert
Ocular Therapeutix (NSDQ:OCUL) said today that the FDA approved its resubmitted application Dextenza, an ocular insert designed to release dexamethasone to relieve pain following ophthalmic surgery. The regulatory win for the Bedford, Mass.-based company comes after much back-and-forth with the FDA; the agency has twice rejected Ocular Therapeutix’s application for Dextenza. Get the full story at our sister […]
Philips recalls lithium-ion defibrillator batteries
Philips Healthcare has issued a worldwide recall of batteries for its HeartStart MRx monitor/defibrillator. The Philips M3538A lithium-ion batteries manufactured from December 28, 2017 to March 20, 2018 for the HeartStart MRx monitor/defibrillator may have an internal component failure and may fail to charge or to provide power, according to a statement by the U.K. Medicines and […]
J&J’s Biosense Webster launches Heliostar multi-electrode ablation cath trial
Johnson & Johnson‘s (NYSE:JNJ) Biosense Webster said this week that it enrolled and treated the first patient in its Stellar U.S. investigational device exemption study. The 640-patient trial is designed to assess the safety and efficacy of the Heliostar multi-electrode radiofrequency balloon ablation catheter as a treatment for drug refractory recurrent paroxysmal atrial fibrillation. The […]
Diabeloop wins CE Mark for hybrid closed-loop diabetes management system
Diabeloop won CE Mark clearance in the European Union this month for its hybrid closed-loop diabetes management system, DBLG1. The Paris-based company hopes to launch its “artificial pancreas” system for adults with Type I diabetes in Europe by the second quarter in 2019. Get the full story at our sister site, Drug Delivery Business News.
Pulmatrix raises $3m in offering
Pulmatrix (NSDQ:PULM) said this week that it inked a deal with an institutional investor to sell 9,375,000 shares of common stock at 32¢ apiece. The Lexington, Mass.-based company expects to reel in $3 million in total gross proceeds from the offering. Get the full story at our sister site, Drug Delivery Business News.
ParaGen Technologies closes $3m bridge funding round
ParaGen Technologies recently closed a $3 million bridge funding round. Ikove Venture Partners managed and organized the round through its network of investors. About 70% of the funds came from 10 different countries. ParaGen has developed a platform scaffold technology that uses tissue engineering to address biologic and synthetic implants. Its four portfolio companies include […]
Monteris Medical scores reimbursement win with Aetna
More epilepsy patients could have access to procedures involving Monteris Medical’s NeuroBlate system after a new coverage update from health insurance giant Aetna. The coverage update, which Monteris Medical announced today, involves Aetna’s medical policy for laser interstitial thermotherapy (LITT). It provides coverage for Aetna beneficiaries with refractory epilepsy who have met the established medical necessity criteria […]
Reshape Lifesciences settles with institutional investors for $700K
Just days after it announced that it had raised $10 million in a registered direct offering, ReShape Lifesciences (NSDQ:RSLS) disclosed in a regulatory filing that it’s paying $350,000 to each of the two institutional investors involved. The U.S. Securities and Exchange Commission filing, dated yesterday, said the money settles a dispute that arose prior to the closing […]